Capricor Therapeutics, Inc. (CAPR): Depreciation & Amortization
$1.89M
Year ended 2025-12-31
$2.09M
Trailing 12 months to 2026-06-30
+52.5%
3-year compound annual growth
+67.4%
5-year compound annual growth
+32.8%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.89M | +32.5% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $1.43M | +33.3% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $1.07M | +100.5% | 2025-03-26, From 2023-01-01 |
| 2022-12-31 | $533.1K | +117.0% | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | $245.7K | +70.8% | 2023-03-17, From 2021-01-01 |
| 2020-12-31 | $143.9K | -16.3% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $172.0K | +9.1% | 2021-03-15, From 2019-01-01 |
| 2018-12-31 | $157.7K | +9.3% | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | $144.2K | +14.7% | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | $125.7K | +13.4% | 2018-03-22, From 2016-01-01 |
| 2015-12-31 | $110.9K | +164.6% | 2017-03-16, From 2015-01-01 |
| 2014-12-31 | $41.9K | +55.6% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $26.9K | +32.4% | 2015-03-16, From 2013-01-01 |
| 2012-12-31 | $20.3K | +170.9% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $7.5K | -41.9% | 2013-06-21, From 2011-01-01 |
| 2010-12-31 | $12.9K | n/a | 2012-04-02, From 2010-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Capricor Therapeutics, Inc. (CAPR) | 2025-12-31 | $1.89M | +32.5% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $4.01B | -58.2% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $384.0K | -24.6% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $2.00B | +13.0% |
| Pfizer Inc (PFE) | 2025-12-31 | $6.59B | -6.0% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $7.50B | +2.2% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $13.84M | -2.6% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $146.0K | -16.1% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $2.31M | -7.1% |
Compare CAPR, BMY, TXMD, LLY side by side · Screen every company in Pharmaceutical Preparations ↗